Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03490760
Title Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Baptist Health South Florida
Indications

pancreatic adenocarcinoma

Therapies

Durvalumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.